- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.03. | Coronado Research Appoints Gary Lyons as EVP of Medical Affairs | ||
| 20.03. | Bristol Myers Squibb Names GM for Saudi Arabia and Gulf Countries | ||
| 19.03. | Sobi Enters Research Collaboration for Development of Gamifant in Sepsis | ||
| 19.03. | OPKO Health, Entera Bio Partner on Oral Dual Agonist GLP-1 | ||
| 19.03. | Advanced Instruments to Acquire and Merge with Nova Biomedical | ||
| 18.03. | Delpharm to Modernize Its Injectable Manufacturing Facility in Boucherville | ||
| 18.03. | Huyabio Taps Paul Spreen as Chief Business Officer | ||
| 18.03. | Kincell Bio Appoints Larry Pitcher as COO | ||
| 17.03. | Taiho to Acquire Araris Biotech in Potential $1.1B Deal | ||
| 17.03. | AstraZeneca, Alteogen Enter License Agreement for Subcutaneous Formulations of Oncology Assets | ||
| 17.03. | iOncologi Acquires TargImmune Therapeutics | ||
| 17.03. | ChromaTan and Landmark Bio Receive NIIMBL Grant | ||
| 17.03. | Curia Expands Global Network of Sterile Fill-Finish Sites | ||
| 17.03. | Humanetics Selects Lifecore Biomedical to Deliver CDMO Services for BIO 300 | ||
| 14.03. | Körber and HighByte Partner to Transform Manufacturing in Life Sciences | ||
| 14.03. | Samsung Invests $10M in CS2 Diagnostics | ||
| 14.03. | South Korea's ENCell Enters Japan CGT Market with CRC MOU | ||
| 14.03. | Azurity Pharmaceuticals Acquires Covis Group | ||
| 13.03. | Batavia Biosciences Partners with VBC & MEVAC to Enhance Vaccine Manufacturing Capabilities in Egypt | ||
| 13.03. | Mallinckrodt and Endo Agree to Combine | ||
| 13.03. | Coronado Research Appoints Nick Littlebury as EVP of Regulatory Affairs | ||
| 13.03. | Bristol Meyers Squibb to Acquire 2seventy bio | ||
| 13.03. | MeiraGTx Enters a Strategic Collaboration with Hologen AI | ||
| 13.03. | Grifols IVIG Shows Promise for Post-Polio Syndrome | ||
| 13.03. | Dsm-Firmenich Launches Taste Solutions Portfolio for Pharmaceutical Applications |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
